Filed: 2/14/2025ACC: 0001583977-25-000001
📋 What this filing means
CORMORANT ASSET MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 48 equity positions with a total reported market value of $1.82B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
48
Positions
$1.82B
Total AUM (reported)
77.17M
Total Shares
Allocation by class
COM$761.11M41.8%
CLASS A ORD$459.96M25.3%
COM NEW$262.70M14.4%
COMMON STOCK$99.70M5.5%
ORDINARY SHARES$87.68M4.8%
SPONSORED ADS$58.50M3.2%
COM PAR $.01$44.88M2.5%
Portfolio Concentration
Top 3$702.70M38.6%
4–10$484.38M26.6%
11–25$450.37M24.7%
Rest$183.41M10.1%
Top 3 weight
38.6%
Top 10 weight
65.2%
Voting Authority Distribution
Total shares with voting rights: 77.17M
Sole
Full voting authority
77.17M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other48
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings48
Rows:
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares8.49M
TypeSH
Market value$459.96M
25.26%
Sole
8.49M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
DFNDShares1.69M
TypeSH
Market value$130.31M
7.16%
Sole
1.69M
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
DFNDShares2.10M
TypeSH
Market value$112.43M
6.17%
Sole
2.10M
Shared
0.00
None
0.00
ARCELLX INC
DFNDShares1.30M
TypeSH
Market value$99.70M
5.48%
Sole
1.30M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
DFNDShares3.41M
TypeSH
Market value$90.95M
5.00%
Sole
3.41M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
DFNDShares3.25M
TypeSH
Market value$83.53M
4.59%
Sole
3.25M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
DFNDShares8.32M
TypeSH
Market value$62.02M
3.41%
Sole
8.32M
Shared
0.00
None
0.00
RAPPORT THERAPEUTICS INC
DFNDShares2.94M
TypeSH
Market value$52.17M
2.87%
Sole
2.94M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
DFNDShares1M
TypeSH
Market value$51.13M
2.81%
Sole
1M
Shared
0.00
None
0.00
INSMED INC
DFNDShares650K
TypeSH
Market value$44.88M
2.46%
Sole
650K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
DFNDShares1.60M
TypeSH
Market value$43.90M
2.41%
Sole
1.60M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
DFNDShares2.56M
TypeSH
Market value$42.91M
2.36%
Sole
2.56M
Shared
0.00
None
0.00
BRIGHT MINDS BIOSCIENCES INC
DFNDShares1.06M
TypeSH
Market value$38.16M
2.10%
Sole
1.06M
Shared
0.00
None
0.00
VAXCYTE INC
DFNDShares425K
TypeSH
Market value$34.79M
1.91%
Sole
425K
Shared
0.00
None
0.00
MERUS N V
DFNDShares740K
TypeSH
Market value$31.12M
1.71%
Sole
740K
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
DFNDShares2.91M
TypeSH
Market value$30.54M
1.68%
Sole
2.91M
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
DFNDShares1.05M
TypeSH
Market value$30.53M
1.68%
Sole
1.05M
Shared
0.00
None
0.00
PHARVARIS N V
DFNDShares1.47M
TypeSH
Market value$28.11M
1.54%
Sole
1.47M
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
DFNDShares2.38M
TypeSH
Market value$28.02M
1.54%
Sole
2.38M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
DFNDShares500K
TypeSH
Market value$27.68M
1.52%
Sole
500K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
DFNDShares325K
TypeSH
Market value$27.50M
1.51%
Sole
325K
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
DFNDShares1.82M
TypeSH
Market value$25.42M
1.40%
Sole
1.82M
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
DFNDShares400K
TypeSH
Market value$22.39M
1.23%
Sole
400K
Shared
0.00
None
0.00
CG ONCOLOGY INC
DFNDShares775K
TypeSH
Market value$22.23M
1.22%
Sole
775K
Shared
0.00
None
0.00
CARGO THERAPEUTICS INC
DFNDShares1.18M
TypeSH
Market value$17.05M
0.94%
Sole
1.18M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 8.49M | SH | $459.96M 25.26% | 8.49M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES IDFND | COM NEW | 1.69M | SH | $130.31M 7.16% | 1.69M | 0.00 | 0.00 |
JANUX THERAPEUTICS INCDFND | COM | 2.10M | SH | $112.43M 6.17% | 2.10M | 0.00 | 0.00 |
ARCELLX INCDFND | COMMON STOCK | 1.30M | SH | $99.70M 5.48% | 1.30M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCDFND | COM | 3.41M | SH | $90.95M 5.00% | 3.41M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYDFND | ORDINARY SHARES | 3.25M | SH | $83.53M 4.59% | 3.25M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCDFND | COM NEW | 8.32M | SH | $62.02M 3.41% | 8.32M | 0.00 | 0.00 |
RAPPORT THERAPEUTICS INCDFND | COM | 2.94M | SH | $52.17M 2.87% | 2.94M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INDFND | COM | 1M | SH | $51.13M 2.81% | 1M | 0.00 | 0.00 |
INSMED INCDFND | COM PAR $.01 | 650K | SH | $44.88M 2.46% | 650K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCDFND | COM | 1.60M | SH | $43.90M 2.41% | 1.60M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCDFND | SPONSORED ADS | 2.56M | SH | $42.91M 2.36% | 2.56M | 0.00 | 0.00 |
BRIGHT MINDS BIOSCIENCES INCDFND | COM NEW | 1.06M | SH | $38.16M 2.10% | 1.06M | 0.00 | 0.00 |
VAXCYTE INCDFND | COM | 425K | SH | $34.79M 1.91% | 425K | 0.00 | 0.00 |
MERUS N VDFND | COM | 740K | SH | $31.12M 1.71% | 740K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IIDFND | CL A ORD SHS | 2.91M | SH | $30.54M 1.68% | 2.91M | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCDFND | COM | 1.05M | SH | $30.53M 1.68% | 1.05M | 0.00 | 0.00 |
PHARVARIS N VDFND | COM | 1.47M | SH | $28.11M 1.54% | 1.47M | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSDFND | COM NEW | 2.38M | SH | $28.02M 1.54% | 2.38M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCDFND | COM | 500K | SH | $27.68M 1.52% | 500K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCDFND | COM | 325K | SH | $27.50M 1.51% | 325K | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCDFND | COM | 1.82M | SH | $25.42M 1.40% | 1.82M | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCDFND | COM | 400K | SH | $22.39M 1.23% | 400K | 0.00 | 0.00 |
CG ONCOLOGY INCDFND | COM | 775K | SH | $22.23M 1.22% | 775K | 0.00 | 0.00 |
CARGO THERAPEUTICS INCDFND | COM | 1.18M | SH | $17.05M 0.94% | 1.18M | 0.00 | 0.00 |
Page 1 of 2